<?xml version="1.0" encoding="utf-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd"><url><loc>https://www.pharmamanufacturing.com/industry-news/news/55418472/evonik-produces-first-gmp-lipid-batch-at-indiana-facility</loc><news:news><news:publication><news:name>Pharma Manufacturing</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-12T16:07:48.000Z</news:publication_date><news:title>Evonik produces first GMP lipid batch at Indiana facility</news:title></news:news></url><url><loc>https://www.pharmamanufacturing.com/industry-news/news/55418467/probiogen-gains-gmp-authorization-for-viral-vectors-vaccines</loc><news:news><news:publication><news:name>Pharma Manufacturing</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-12T15:56:49.000Z</news:publication_date><news:title>ProBioGen gains authorization for viral vectors, vaccines</news:title></news:news></url><url><loc>https://www.pharmamanufacturing.com/industry-news/news/55418209/simtra-opens-250m-sterile-injectable-manufacturing-addition-in-indiana</loc><news:news><news:publication><news:name>Pharma Manufacturing</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-11T17:24:50.000Z</news:publication_date><news:title>Simtra opens $250M sterile injectable manufacturing addition in Indiana</news:title></news:news></url><url><loc>https://www.pharmamanufacturing.com/industry-news/news/55418205/maxcyte-to-buy-akron-bio-in-1518m-cell-therapy-manufacturing-deal</loc><news:news><news:publication><news:name>Pharma Manufacturing</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-11T17:20:44.000Z</news:publication_date><news:title>MaxCyte to buy Akron Bio in $151.8M cell therapy manufacturing deal</news:title></news:news></url></urlset>